There’s only a couple of days left to lock in the ResMed dividend.
The post Hoping to bag the Resmed dividend? Read this appeared first on The Motley Fool Australia. –
ResMed Inc (ASX: RMD) shareholders are mostly likely feeling frustrated after the share price has seesawed in 2022.
The sleep treatment focused medical device company released its third quarter results late last month.
After falling short of the market’s estimates for revenue and earnings, ResMed shares sank 4.08% on the day.
Nonetheless, the board opted to ramp up its upcoming quarterly dividend to eligible investors.
Let’s take a look below at what you need to know in regards to the latest dividend.
What’s the deal with the ResMed dividend?
The ResMed share price backtracked as investors vented their disappointment following the company’s financial scorecard for the March quarter.
The company is set to pay out US 4.2 cents per share for the 3 months ending 31 March 2022. That’s 7.69% higher than the prior corresponding period dividend of US 3.9 cents per share.
Management, however, noted there may still be uncertainty associated with COVID-19 over the next year. Nonetheless, its long-term strategy is focused on supporting 250 million people in 2025.
The higher dividend came on the back of the company recording a 12% increase in revenue to $864.5 million.
When can shareholders expect to be paid?
ResMed will pay the latest dividend to eligible shareholders on 16 June 2022.
However, to be eligible you’ll need to own ResMed shares before the ex-dividend date which falls on Wednesday 11 May. This means if you want to secure the dividend, you will need to purchase the company’s shares by tomorrow at the latest.
It is worth noting that on the ex-dividend day, the share price traditionally falls in proportion to the dividend amount.
In addition, the dividend is not franked which means that investors will miss out on the tax credits.
Currently, ResMed has a dividend trailing yield of 0.56% and a market capitalisation of roughly $11.44 billion.
Should you invest $1,000 in ResMed right now?
Before you consider ResMed, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and ResMed wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of January 13th 2022
Guess which ASX 200 shares are defying today’s sell-off to climb higher
2 medical tech ASX shares Morgans loves right now
Leading brokers name 3 ASX shares to buy today
5 things to watch on the ASX 200 on Monday
These were the worst performing ASX 200 shares last week
Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.